Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
for
Acute Lymphocytic Leukemia
Location: Boston MA, Cleveland OH, Columbus OH, Omaha NE
Sponsor: Leland Metheny
Sex: All
Age: 16 - 70+
Code: NCT03104491
Phase1, Phase2, Recruiting
Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma
for
Recurrent Astrocytoma, IDH-Mutant, Grade 3,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT06815029
Phase1, Recruiting
Uterine Preservation Via Lifestyle Transformation
for
Endometrial Hyperplasia, Grade 1 Endometrial Cancer
Location: St Louis MO, Oklahoma City OK, Albuquerque NM
Sponsor: Washington University School of Medicine
Sex: Female
Age: 18+
Code: NCT05903131
Phase2, Recruiting
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Weymouth MA, Boston MA, Brighton MA, Methuen MA,
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT02269592
Recruiting
Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies
for
Leukemia, Acute Lymphoblastic Leukemia
Location: Palo Alto CA
Sponsor: Stanford University
Sex: All
Age: 1 - 25
Code: NCT06408194
Phase1, Recruiting
Interested in new lymphoma trials?
Get alerts for new trials in your area by subscribing now
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
for
Acute Lymphoblastic Leukemia, B-All
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 3 - 65
Code: NCT07328503
Phase2, Recruiting
Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology